Hong Kong Stock Movement | SINOPHARM (01099) Rises Over 3% Ahead of Q3 Results; China National Medicines Reports 13.1% YoY Profit Growth
Stock News
Oct 22
According to reports, SINOPHARM (01099) is up over 3%, currently rising 3.26% to HKD 19.33, with a trading volume of HKD 71.91 million. On the news front, SINOPHARM will hold a board meeting on October 24 to discuss and approve the unaudited quarterly results for the nine months ending September 30, 2025, for the company and its subsidiaries. Its subsidiary, China National Medicines Corporation Ltd. achieved a revenue of RMB 13.747 billion for the third quarter, a year-on-year increase of 3.58%, while the net profit attributable to shareholders of the listed company was RMB 544 million, marking a 13.10% year-on-year growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.